Harness the power of artificial intelligence, multimodal ophthalmic imaging and big data to provide previously-unavailable stratification, prognostication and treatment recommendations for patients with ophthalmic diseases.
Usher in an era of personalized ophthalmic care and transform the field of ophthalmology using artificial intelligence.
Questions we're asking that inform us on how to best care for patients include:
Can we develop an algorithm that provides fine-grained predictions for conversion to wet age-related macular degeneration (AMD) in patients with dry AMD?
Can we identify the optimal intravitreal anti-VEGF medication for patients with retinal vascular diseases at treatment initiation?
The Wilmer Eye Institute is the largest academic ophthalmology department in the United States, providing top-notch clinical care across all ophthalmic subspecialities. Learn more about our variety of eye care services.